209 related articles for article (PubMed ID: 25747777)
1. In silico analysis of binding of neurotoxic venom ligands with acetylcholinesterase for therapeutic use in treatment of Alzheimer's disease.
Waqar M; Batool S
J Theor Biol; 2015 May; 372():107-17. PubMed ID: 25747777
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target.
Harel M; Kleywegt GJ; Ravelli RB; Silman I; Sussman JL
Structure; 1995 Dec; 3(12):1355-66. PubMed ID: 8747462
[TBL] [Abstract][Full Text] [Related]
3. Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesterase.
van den Born HK; Radić Z; Marchot P; Taylor P; Tsigelny I
Protein Sci; 1995 Apr; 4(4):703-15. PubMed ID: 7613468
[TBL] [Abstract][Full Text] [Related]
4. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II.
Kryger G; Harel M; Giles K; Toker L; Velan B; Lazar A; Kronman C; Barak D; Ariel N; Shafferman A; Silman I; Sussman JL
Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1385-94. PubMed ID: 11053835
[TBL] [Abstract][Full Text] [Related]
5. In Silico Analysis of Binding Interaction of Mamba Toxins with M4 and M2 Muscarinic Acetylcholine Receptors for Therapeutic Use in Alzheimer's Disease.
Waqar M; Kamal MA; Batool S
CNS Neurol Disord Drug Targets; 2015; 14(8):1031-40. PubMed ID: 26295818
[TBL] [Abstract][Full Text] [Related]
6. Rapid ligand fishing for identification of acetylcholinesterase-binding peptides in snake venom reveals new properties of dendrotoxins.
Vanzolini KL; Ainsworth S; Bruyneel B; Herzig V; Seraus MGL; Somsen GW; Casewell NR; Cass QB; Kool J
Toxicon; 2018 Sep; 152():1-8. PubMed ID: 29990530
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mouse acetylcholinesterase by fasciculin: crystal structure of the complex and mutagenesis of fasciculin.
Marchot P; Bourne Y; Prowse CN; Bougis PE; Taylor P
Toxicon; 1998 Nov; 36(11):1613-22. PubMed ID: 9792178
[TBL] [Abstract][Full Text] [Related]
8. Mapping of the binding landscape for a picomolar protein-protein complex through computation and experiment.
Aizner Y; Sharabi O; Shirian J; Dakwar GR; Risman M; Avraham O; Shifman J
Structure; 2014 Apr; 22(4):636-45. PubMed ID: 24613488
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterases from Elapidae snake venoms: biochemical, immunological and enzymatic characterization.
Frobert Y; Créminon C; Cousin X; Rémy MH; Chatel JM; Bon S; Bon C; Grassi J
Biochim Biophys Acta; 1997 May; 1339(2):253-67. PubMed ID: 9187246
[TBL] [Abstract][Full Text] [Related]
10. [The fasciculin-acetylcholinesterase interaction].
Marchot P
J Soc Biol; 1999; 193(6):505-8. PubMed ID: 10783708
[TBL] [Abstract][Full Text] [Related]
11. Preliminary X-ray analysis of crystals of fasciculin 1, a potent acetylcholinesterase inhibitor from green mamba venom.
Ménez R; Ducruix A
J Mol Biol; 1990 Nov; 216(2):233-4. PubMed ID: 2254925
[TBL] [Abstract][Full Text] [Related]
12. Fasciculins, anticholinesterase toxins from the venom of the green mamba Dendroaspis angusticeps.
Karlsson E; Mbugua PM; Rodriguez-Ithurralde D
J Physiol (Paris); 1984; 79(4):232-40. PubMed ID: 6530667
[TBL] [Abstract][Full Text] [Related]
13. Conformational transitions in protein-protein association: binding of fasciculin-2 to acetylcholinesterase.
Bui JM; Radic Z; Taylor P; McCammon JA
Biophys J; 2006 May; 90(9):3280-7. PubMed ID: 16473897
[TBL] [Abstract][Full Text] [Related]
14. Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals.
Amat-Ur-Rasool H; Ahmed M
PLoS One; 2015; 10(9):e0136509. PubMed ID: 26325402
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of acetylcholinesterase inhibition by fasciculin: a 5-ns molecular dynamics simulation.
Tai K; Shen T; Henchman RH; Bourne Y; Marchot P; McCammon JA
J Am Chem Soc; 2002 May; 124(21):6153-61. PubMed ID: 12022850
[TBL] [Abstract][Full Text] [Related]
16. A new role for the nonpathogenic nonsynonymous single-nucleotide polymorphisms of acetylcholinesterase in the treatment of Alzheimer's disease: a computational study.
Saravanaraman P; Chinnadurai RK; Boopathy R
J Comput Biol; 2014 Aug; 21(8):632-47. PubMed ID: 24611490
[TBL] [Abstract][Full Text] [Related]
17. 1.9-A resolution structure of fasciculin 1, an anti-acetylcholinesterase toxin from green mamba snake venom.
le Du MH; Marchot P; Bougis PE; Fontecilla-Camps JC
J Biol Chem; 1992 Nov; 267(31):22122-30. PubMed ID: 1429564
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of a chimeric peptide derived from fasciculin that inhibits acetylcholinesterase.
Falkenstein RJ; Gornalusse GG; Peña C
J Pept Sci; 2004 Jun; 10(6):342-9. PubMed ID: 15214439
[TBL] [Abstract][Full Text] [Related]
19. Quantifying ligand-receptor interactions for gorge-spanning acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Martis EA; Chandarana RC; Shaikh MS; Ambre PK; D'Souza JS; Iyer KR; Coutinho EC; Nandan SR; Pissurlenkar RR
J Biomol Struct Dyn; 2015; 33(5):1107-25. PubMed ID: 24905476
[TBL] [Abstract][Full Text] [Related]
20. Electron paramagnetic resonance reveals altered topography of the active center gorge of acetylcholinesterase after binding of fasciculin to the peripheral site.
Sentjurc M; Pecar S; Stojan J; Marchot P; Radić Z; Grubic Z
Biochim Biophys Acta; 1999 Mar; 1430(2):349-58. PubMed ID: 10082962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
